Michael Cooper
No más puestos en curso
Perfil
Michael Cooper served as the Chief Medical Officer at Constellation Pharmaceuticals, Inc. Prior to that, he obtained an undergraduate degree from Duke University.
Antiguos cargos conocidos de Michael Cooper.
| Empresas | Cargo | Fin |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
Formación de Michael Cooper.
| Duke University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Cooper